Exagen Inc.
General ticker "XGN" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $143.9M (TTM average)
Exagen Inc. does not follow the US Stock Market performance with the rate: -8.0%.
Estimated limits based on current volatility of 5.2%: low 4.80$, high 5.33$
Factors to consider:
- Total employees count: 209 (+16.8%) as of 2024
- Top business risk factors: Third-party risks, Single supplier dependency, Labor/talent shortage/retention, Strategic risks and growth management, Market acceptance
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.53$, 9.84$]
- 2026-12-31 to 2027-12-31 estimated range: [3.72$, 8.36$]
Financial Metrics affecting the XGN estimates:
- Negative: with PPE of -8.1 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of -0.46 > -0.60
- Positive: Interest expense per share per price, % of 3.20 <= 3.31
- Positive: Industry inventory ratio change (median), % of 0 <= 0.28
- Positive: Inventory ratio change, % of -1.00 <= -0.75
Short-term XGN quotes
Long-term XGN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $52.55MM | $55.64MM | $66.58MM |
| Operating Expenses | $75.39MM | $69.28MM | $80.64MM |
| Operating Income | $-22.84MM | $-13.64MM | $-14.07MM |
| Non-Operating Income | $-0.82MM | $-1.47MM | $-5.83MM |
| Interest Expense | $2.33MM | $2.23MM | $4.32MM |
| R&D Expense | $4.87MM | $5.38MM | $6.25MM |
| Income(Loss) | $-23.66MM | $-15.10MM | $-19.90MM |
| Taxes | $0.03MM | $0.01MM | $0.05MM |
| Net Income(Loss)* | $-23.69MM | $-15.12MM | $-19.95MM |
| Stockholders Equity | $22.69MM | $9.54MM | $17.45MM |
| Assets | $56.94MM | $44.69MM | $58.02MM |
| Operating Cash Flow | $-14.46MM | $-13.28MM | $-13.62MM |
| Capital expenditure | $0.83MM | $0.52MM | $0.64MM |
| Investing Cash Flow | $-0.80MM | $-0.52MM | $-0.63MM |
| Financing Cash Flow | $-10.63MM | $-0.66MM | $24.43MM |
| Earnings Per Share** | $-1.34 | $-0.83 | $-0.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.